Citius Oncology (CTOR) Other Operating Expenses (2023 - 2026)

Citius Oncology (CTOR) has 4 years of Other Operating Expenses data on file, last reported at $4.7 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 207.71% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 13.21% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 28.97% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $4.7 million, up from $4.0 million in the prior quarter.
• Over the last five years, Other Operating Expenses for CTOR reached as high as $6.6 million in Q2 2024 and fell as low as -$2.1 million in Q3 2025.
• Historically, Other Operating Expenses has averaged $2.5 million across 4 years, with a median of $2.2 million in 2023.
• On a YoY basis, Other Operating Expenses climbed as much as 224.98% in 2025 and fell as far as 76.57% in 2025.
• Year by year, Other Operating Expenses stood at $2.2 million in 2023, then tumbled by 42.57% to $1.2 million in 2024, then soared by 224.98% to $4.0 million in 2025, then grew by 16.06% to $4.7 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $4.7 million in Q1 2026, $4.0 million in Q4 2025, and -$2.1 million in Q3 2025.